What are the major opportunities in the Oncology Companion Diagnostics market? What are the strategies for the Oncology Companion Diagnostics market?

For detailed insights on the major opportunities and strategies in the Oncology Companion Diagnostics market, Read More

How does the Oncology Companion Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Oncology Companion Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Oncology Companion Diagnostics market growth? SWOT analysis of the Oncology Companion Diagnostics market.

For detailed insights on the key dynamics influencing the Oncology Companion Diagnostics market growth and SWOT analysis of the Oncology Companion Diagnostics industry, Read More

Oncology Companion Diagnostics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Oncology Companion Diagnostics Market Report 2026

Name: Oncology Companion Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Instrument, Consumables, Software), By Disease Type (Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease Types), By Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH) Or Fluorescence In Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies), By End User (Hospital, Pathology Or Diagnostic Laboratory, Academic Medical Center, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Oncology Companion Diagnostics Market Overview

• Oncology Companion Diagnostics market size has reached to $3.79 billion in 2025

• Expected to grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Rise In Cancer Cases Fuels Growth In Oncology Companion Diagnostics Market

• Market Trend: Advancements in c-MET (Mesenchymal-Epithelial Transition) Companion Diagnostics for Precision Oncology in Non-Small Cell Lung Cancer (NSCLC)

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oncology Companion Diagnostics Market?

Oncology companion diagnostics are medical tests that identify specific biomarkers, indicating which patients are most likely to benefit from a particular cancer treatment. These diagnostics are essential for developing and applying targeted therapies, as they help ensure that treatments are tailored to the individual characteristics of a patient's tumor. Companion diagnostics provide insights into the molecular and genetic profile of the cancer, enabling more personalized and effective treatment plans, improving outcomes, and minimizing unnecessary side effects.

The main products of the oncology companion diagnostics market are instruments, consumables, and software. Instruments refer to a wide range of tools, devices, or objects used for various purposes across different fields. The various disease types include melanoma, breast cancer, colorectal cancer, leukemia, prostate cancer, and other disease types used by various technologies such as immunohistochemistry (IHC), in situ hybridization (ISH) or fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), next-generation sequencing (NGS), and other technologies used by various end users including hospital, pathology or diagnostic laboratory, academic medical center, and others.

Oncology Companion Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Oncology Companion Diagnostics Market Size and Share 2026?

The oncology companion diagnostics market size has grown rapidly in recent years. It will grow from $3.79 billion in 2025 to $4.29 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to rising prevalence of cancer types such as breast, colorectal, and melanoma, increasing focus on personalized medicine, growing demand for targeted therapy selection, expansion of diagnostic laboratories and hospitals, development of molecular and genetic testing technologies.

What Is The Oncology Companion Diagnostics Market Growth Forecast?

The oncology companion diagnostics market size is expected to see rapid growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to rising adoption of next-generation sequencing (ngs) and pcr-based diagnostics, increasing collaboration between pharma and diagnostic companies, growth in regulatory approvals for companion diagnostics, rising demand for precision oncology, increasing use of bioinformatics and decision support software in diagnostics. Major trends in the forecast period include rising adoption of digital platforms for companion diagnostic data management, increasing integration of ai in biomarker analysis and patient stratification, growing use of genomics and precision medicine in targeted cancer therapy, rising automation in diagnostic testing and laboratory workflows, increasing iot-enabled monitoring of diagnostic instruments and reagents.

Book your 30 minutes free consultation with our research experts

Global Oncology Companion Diagnostics Market Segmentation

1) By Product: Instrument, Consumables, Software

2) By Disease Type: Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease Types

3) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH) Or Fluorescence In Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies

4) By End User: Hospital, Pathology Or Diagnostic Laboratory, Academic Medical Center, Other End-Users

Subsegments:

1) By Instrument: Polymerase Chain Reaction (PCR) Instruments, Next-Generation Sequencing (NGS) Systems, Immunohistochemistry (IHC) Instruments, Fluorescence In Situ Hybridization (FISH) Instruments, Microarray Platforms

2) By Consumables: Reagents And Kits (DNA Or RNA Extraction Kits, PCR Reagents), Biopsy Needles, Testing Slides And Chips, Control And Calibration Samples

3) By Software: Data Analysis Software, Bioinformatics Software (For Gene Expression Analysis), Companion Diagnostic Decision Support Software, Clinical Workflow Management Software

What Is The Driver Of The Oncology Companion Diagnostics Market?

A rise in cancer cases is expected to propel the growth of the oncology companion diagnostics market going forward. Cancer is a complex group of diseases caused by abnormal cells in the body that grow and spread uncontrollably. The increase in cancer cases is due to changes in lifestyle, environmental factors, the obesity epidemic, tobacco use, and genetic factors. Oncology companion diagnostics contribute to precision medicine approaches in oncology, revolutionizing cancer care by enabling personalized treatment selection, improving treatment efficacy, minimizing adverse effects, facilitating clinical trial enrollment, and enhancing treatment monitoring. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, around 20 million new cases and 9.7 million cancer-related deaths were recorded annually in 2022, and predictions indicate that by 2040, there would be 15.3 million deaths and 29.9 million new cases per year. Therefore, a rise in cancer cases drives the oncology companion diagnostics industry.

Key Players In The Global Oncology Companion Diagnostics Market

Major companies operating in the oncology companion diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, BGI Genomics Co. Ltd., Natera Inc., Myriad Genetics Inc., ARUP Laboratories, NeoGenomics Laboratories Inc., Guardant Health, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Invivoscribe Inc., Pillar Biosciences Inc.

Global Oncology Companion Diagnostics Market Trends and Insights

Major companies operating in the oncology companion diagnostics market are focusing on developing advanced high-throughput sequencing technologies, such as c-MET companion diagnostic assay implementation for therapeutic guidance in advanced non-small cell lung cancer, to enhance precision oncology and individualized treatment selection. c-MET companion diagnostic assay implementation for therapeutic guidance in advanced non-small cell lung cancer refers to the deployment of a targeted diagnostic test designed to detect c-MET gene alterations in patients with advanced non-small cell lung cancer (NSCLC), enabling clinicians to select appropriate therapies, optimize treatment efficacy, and support precision medicine approaches. For instance, in May 2025, NeoGenomics, Inc., a US-based oncology testing company, launched its c-MET CDx Assay to guide treatment decisions in patients with advanced Non-Small Cell Lung Cancer (NSCLC). The c-MET CDx Assay is a companion diagnostic test designed to detect c-MET protein overexpression in tumor tissue, providing rapid and accurate results to identify patients who may benefit from MET-targeted therapies. The assay offers high sensitivity and specificity, fast turnaround times, standardized testing procedures, and compatibility with routine clinical workflows, making it ideal for precision oncology and personalized treatment planning.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Oncology Companion Diagnostics Market?

In January 2024, Agilent Technologies Inc., a US-based diagnostics company, partnered with Incyte Corporation for an undisclosed amount. With this partnership, Agilent aims to enhance its companion diagnostics portfolio and support Incyte’s hematology and oncology treatments with advanced, precision diagnostics. Incyte Corporation is a US-based pharmaceutical company that specializes in the development and commercialization of oncology medications.

Regional Outlook

North America was the largest region in the oncology companion diagnostic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oncology Companion Diagnostics Market?

The oncology companion diagnostics market consists of revenues earned by entities by providing services such as biomarker testing, patient stratification, monitoring treatment response, predicting drug resistance, clinical trial enrollment, comprehensive genomic testing, therapy resistance testing, hereditary cancer testing, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The oncology companion diagnostics market also includes sales of polymerase chain reaction instruments, immunohistochemistry (IHC) staining kits, companion diagnostic test kits, liquid biopsy platforms, gene expression profiling kits, mass spectrometry systems, flow cytometry analyzers, tissue microarray instruments, and electrochemical biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncology Companion Diagnostics Market Report 2026?

The oncology companion diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology companion diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Oncology Companion Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.29 billion
Revenue Forecast In 2035	$6.5 billion
Growth Rate	CAGR of 13.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Disease Type, Technology, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, BGI Genomics Co. Ltd., Natera Inc., Myriad Genetics Inc., ARUP Laboratories, NeoGenomics Laboratories Inc., Guardant Health, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Invivoscribe Inc., Pillar Biosciences Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oncology Companion Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oncology Companion Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oncology Companion Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oncology Companion Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Digitalization, Cloud, Big Data & Cybersecurity

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Biotechnology, Genomics & Precision Medicine

4.2. Major Trends

4.2.1 Rising Adoption Of Digital Platforms For Companion Diagnostic Data Management

4.2.2 Increasing Integration Of Ai In Biomarker Analysis And Patient Stratification

4.2.3 Growing Use Of Genomics And Precision Medicine In Targeted Cancer Therapy

4.2.4 Rising Automation In Diagnostic Testing And Laboratory Workflows

4.2.5 Increasing Iot-Enabled Monitoring Of Diagnostic Instruments And Reagents

5. Oncology Companion Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Pathology Or Diagnostic Laboratories

5.3 Academic Medical Centers

5.4 Research Institutes

5.5 Pharmaceutical And Biotechnology Companies

6. Oncology Companion Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Companion Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oncology Companion Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oncology Companion Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oncology Companion Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oncology Companion Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Companion Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Companion Diagnostics Market Segmentation

9.1. Global Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instrument, Consumables, Software

9.2. Global Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease Types

9.3. Global Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunohistochemistry (IHC), In Situ Hybridization (ISH) Or Fluorescence In Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies

9.4. Global Oncology Companion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Pathology Or Diagnostic Laboratory, Academic Medical Center, Other End-Users

9.5. Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR) Instruments, Next-Generation Sequencing (NGS) Systems, Immunohistochemistry (IHC) Instruments, Fluorescence In Situ Hybridization (FISH) Instruments, Microarray Platforms

9.6. Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reagents And Kits (DNA Or RNA Extraction Kits, PCR Reagents), Biopsy Needles, Testing Slides And Chips, Control And Calibration Samples

9.7. Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Data Analysis Software, Bioinformatics Software (For Gene Expression Analysis), Companion Diagnostic Decision Support Software, Clinical Workflow Management Software

10. Oncology Companion Diagnostics Market Regional And Country Analysis

10.1. Global Oncology Companion Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oncology Companion Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Companion Diagnostics Market

11.1. Asia-Pacific Oncology Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Companion Diagnostics Market

12.1. China Oncology Companion Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Companion Diagnostics Market

13.1. India Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Companion Diagnostics Market

14.1. Japan Oncology Companion Diagnostics Market Overview

14.2. Japan Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Companion Diagnostics Market

15.1. Australia Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Companion Diagnostics Market

16.1. Indonesia Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Companion Diagnostics Market

17.1. South Korea Oncology Companion Diagnostics Market Overview

17.2. South Korea Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oncology Companion Diagnostics Market

18.1. Taiwan Oncology Companion Diagnostics Market Overview

18.2. Taiwan Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oncology Companion Diagnostics Market

19.1. South East Asia Oncology Companion Diagnostics Market Overview

19.2. South East Asia Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oncology Companion Diagnostics Market

20.1. Western Europe Oncology Companion Diagnostics Market Overview

20.2. Western Europe Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oncology Companion Diagnostics Market

21.1. UK Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oncology Companion Diagnostics Market

22.1. Germany Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oncology Companion Diagnostics Market

23.1. France Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oncology Companion Diagnostics Market

24.1. Italy Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oncology Companion Diagnostics Market

25.1. Spain Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oncology Companion Diagnostics Market

26.1. Eastern Europe Oncology Companion Diagnostics Market Overview

26.2. Eastern Europe Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oncology Companion Diagnostics Market

27.1. Russia Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oncology Companion Diagnostics Market

28.1. North America Oncology Companion Diagnostics Market Overview

28.2. North America Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oncology Companion Diagnostics Market

29.1. USA Oncology Companion Diagnostics Market Overview

29.2. USA Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oncology Companion Diagnostics Market

30.1. Canada Oncology Companion Diagnostics Market Overview

30.2. Canada Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oncology Companion Diagnostics Market

31.1. South America Oncology Companion Diagnostics Market Overview

31.2. South America Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oncology Companion Diagnostics Market

32.1. Brazil Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oncology Companion Diagnostics Market

33.1. Middle East Oncology Companion Diagnostics Market Overview

33.2. Middle East Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oncology Companion Diagnostics Market

34.1. Africa Oncology Companion Diagnostics Market Overview

34.2. Africa Oncology Companion Diagnostics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oncology Companion Diagnostics Market Regulatory and Investment Landscape

36. Oncology Companion Diagnostics Market Competitive Landscape And Company Profiles

36.1. Oncology Companion Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oncology Companion Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oncology Companion Diagnostics Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis

37. Oncology Companion Diagnostics Market Other Major And Innovative Companies

Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, BGI Genomics Co. Ltd., Natera Inc., Myriad Genetics Inc., ARUP Laboratories, NeoGenomics Laboratories Inc.

38. Global Oncology Companion Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oncology Companion Diagnostics Market

40. Oncology Companion Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Oncology Companion Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Oncology Companion Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Oncology Companion Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Oncology Companion Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Oncology Companion Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Oncology Companion Diagnostics Market, Supply Chain Analysis

Table 4: Global Oncology Companion Diagnostics Market, Major Raw Material Providers

Table 5: Global Oncology Companion Diagnostics Market, Major Resource Providers

Table 6: Global Oncology Companion Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Oncology Companion Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Oncology Companion Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Oncology Companion Diagnostics Market, Major Trends

Table 10: Global Oncology Companion Diagnostics Market, Major End Users

Table 11: Global Oncology Companion Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Oncology Companion Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Oncology Companion Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Oncology Companion Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Oncology Companion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Oncology Companion Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Oncology Companion Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Oncology Companion Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Oncology Companion Diagnostics Market - Company Scoring Matrix

Table 98: F. Hoffmann-La Roche AG Financial Performance

Table 99: Thermo Fisher Scientific Inc. Financial Performance

Table 100: Abbott Laboratories Financial Performance

Table 101: Danaher Corporation Financial Performance

Table 102: Laboratory Corporation of America Holdings (LabCorp) Financial Performance

Table 103: Global Oncology Companion Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Oncology Companion Diagnostics Market, Competitive Dashboard

Table 105: Global Oncology Companion Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Oncology Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 107: Global, Oncology Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Table 108: Global, Oncology Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

Figure 1: Global Oncology Companion Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Oncology Companion Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Oncology Companion Diagnostics Market, Supply Chain Analysis

Figure 4: Global Oncology Companion Diagnostics Market, Major Raw Material Providers

Figure 5: Global Oncology Companion Diagnostics Market, Major Resource Providers

Figure 6: Global Oncology Companion Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Oncology Companion Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Oncology Companion Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Oncology Companion Diagnostics Market, Major Trends

Figure 10: Global Oncology Companion Diagnostics Market, Major End Users

Figure 11: Global Oncology Companion Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Oncology Companion Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Oncology Companion Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Oncology Companion Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Oncology Companion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Oncology Companion Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Oncology Companion Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Oncology Companion Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Oncology Companion Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Oncology Companion Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Oncology Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Oncology Companion Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Oncology Companion Diagnostics Market - Company Scoring Matrix

Figure 98: F. Hoffmann-La Roche AG Financial Performance

Figure 99: Thermo Fisher Scientific Inc. Financial Performance

Figure 100: Abbott Laboratories Financial Performance

Figure 101: Danaher Corporation Financial Performance

Figure 102: Laboratory Corporation of America Holdings (LabCorp) Financial Performance

Figure 103: Global Oncology Companion Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Oncology Companion Diagnostics Market, Competitive Dashboard

Figure 105: Global Oncology Companion Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Oncology Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 107: Global, Oncology Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Figure 108: Global, Oncology Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Sulfur Market Report 2026 - Global Outlook – By Type (Fertilizers, Chemical Processing, Sulfur-Metal Manufacturing, Petroleum Refining, Other Types), By Mining Type (Underground Mining, Surface Mining), By End-Use (Agric...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Allogeneic T Cell Therapies Market Report 2026 - Global Outlook – By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, C...

Oncology Devices Market Report 2026 - Global Outlook – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy), By End User (Hosp...

Catamarans Market Report 2026 - Global Outlook – By Product (Sailing Catamarans, Powered Catamarans), By Size (Small (below 15m), Medium (15m-30m)), By Application (Leisure And Recreation, Charter And Tourism, Passenger ...

Air-Dried Food Market Report 2026 - Global Outlook – By Product (Fruits And Vegetables, Herbs And Spices, Meat And Seafood, Other Products), By Form (Powder, Granules, Flakes), By Distribution Channel (Supermarkets And H...

Breast Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridizati...

Frequently Asked Questions

How big is the Oncology Companion Diagnostics Market?

The Oncology Companion Diagnostics market was valued at $3.79 billion in 2025, increased to $4.29 billion in 2026, and is projected to reach $6.5 billion by 2030.

What is the Oncology Companion Diagnostics market growth?

The global Oncology Companion Diagnostics market is expected to grow at a CAGR of 10.9% from 2026 to 2035 to reach $6.5 billion by 2035.

Who are the key players in Oncology Companion Diagnostics market?

Some Key Players in the Oncology Companion Diagnostics market Include, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporat

Major trend in this market includes: Advancements in c-MET (Mesenchymal-Epithelial Transition) Companion Diagnostics for Precision Oncology in Non-Small Cell Lung Cancer (NSCLC) . For further insights on this market. request a sample here

North America was the largest region in the oncology companion diagnostic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology companion diagnostics market repo

Book your 30 minutes free consultation with our research experts

Contact Us